Innovations In Clinical Neuroscience

MAY-JUN 2017

A peer-reviewed, evidence-based journal for clinicians in the field of neuroscience

Issue link:

Contents of this Issue


Page 32 of 35

[ V O L U M E 1 4 , N U M B E R 3 – 4 , M A Y – J U N E 2 0 1 7 ] Innovations in CLINICAL NEUROSCIENCE 33 AI AND VR COULD COMPLETELY TRANSFORM HOW DOCTORS DIAGNOSE AND TREAT MENTAL DISORDERS Many recent studies have looked into the relationship between deep learning, virtual reality (VR), and artificial intelligence (AI) with clinical psychology. One recent study used computational psychiatry in the treatment of borderline personality disorder (BPD). AI has also been used to find patterns in data to help diagnose other mental disorders. * Full story IBM AND UNIVERSITY OF ALBERTA PRESENT NEW DATA ON MACHINE LEARNING ALGORITHMS TO HELP PREDICT SCHIZOPHRENIA Data from IBM scientists and the University of Alberta in Edmonton, Canada, have been published in Nature's partner journal, Schizophrenia, that demonstrates that AI and machine learning algorithms can predict instances of schizophrenia with 74-percent accuracy. This retrospective analysis also showed that the technology predicted the severity of specific symptoms in schizophrenia patients with significant correlations between activity observed across different regions of the brain. * Full story CAN TELEMEDICINE TRANSFORM THE MENTAL HEALTH CARE DELIVERY MODEL? Many people with mental health disorders go undiagnosed, and this issue could be helped by telemedicine, which allows patients to have video conferences with their doctors and health specialists. This could extend care to those who previously might have been too far away from medical professionals to receive it. * Full story SLEEP TECHNOLOGY WAKES UP The market for sleep technology has continued to expand as millions of Americans still lack the proper average hours of sleep per day. For example, Sleep Number's 360 Smart Bed and REM-Fit's pillow mildly vibrate when someone is sleeping to push them into a new sleeping position and help future snoring. * Full story MYOMO, INC. OBTAINS CE MARK APPROVAL FOR MYOPRO® Myomo, Inc. announced that it has obtained CE Mark approval for commercial sale of its next- generation MyoPro myoelectric arm orthosis across the European Economic Area (EEA). The CE Mark indicates MyoPro complies with the essential requirements of relevant EU legislation and has achieved quality system certification. MyoPro is a lightweight wearable device used to restore function in the paralyzed or weakened arms and hands of individuals who have suffered a stroke, spinal cord or nerve injury, or other neuromuscular disability. * Full story VERILY'S STUDY WATCH TO BE FEATURED IN MAJOR PTSD TRIAL Verily, formerly of Google's life sciences division, will begin a multisite trial called the Aurora Study, which will implement a study watch to track heart rate, electrodermal activity, and inertial movements, in conjunction with other smartphone- based technology. * Full story MICROSOFT WORD'S LATEST FEATURE TO HELP DYSLEXICS Microsoft Word now has a "Read Aloud" function that is aimed to help those with dyslexia. This update will be included in the company's Office 365 update, and the company hopes to continue to develop features such as this one to help people with learning or mental disabilities. * Full story N E W S & T R E N D S Exploring the internet for the latest reports on research, products, and trends in neuroscience Innov Clin Neurosci. 2017;14(5–6):33–34 Click the * to link to full story.

Articles in this issue

Links on this page

Archives of this issue

view archives of Innovations In Clinical Neuroscience - MAY-JUN 2017